Quick Answer
ADAPTIN BIO, INC. reported Cash and Equivalents of $380.00 for fiscal year 2023.
ADAPTIN BIO, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2023 | $380.00 | -24.0% |
| 2022 | $500.00 | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $579.1K | — | +1599.0% |
| December 31, 2024 | $34.1K | +8869.7% | +8869.7% |
| March 31, 2024 | $380.00 | — | +0.0% |
| December 31, 2023 | $380.00 | -24.0% | +0.0% |
| September 30, 2023 | $380.00 | — | -24.0% |
| December 31, 2022 | $500.00 | — | — |
- ADAPTIN BIO, INC. showed a decrease of -24.0% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2022–2023 period, ADAPTIN BIO, INC.’s cash and equivalents has declined by 24.0% (from $500.00 to $380.00).
- The most recent figure is from ADAPTIN BIO, INC.’s fiscal year 2023 report (Form 10-K), filed with the SEC on April 1, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: